<DOC>
	<DOC>NCT00854009</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and tolerability of single doses of BLI-489 administered intravenously in healthy Japanese male subjects, and how the drug is absorbed and eliminated.</brief_summary>
	<brief_title>Study Evaluating Single Doses of BLI-489 in Healthy Japanese Male Subjects</brief_title>
	<detailed_description />
	<mesh_term>BLI-489</mesh_term>
	<criteria>1. Men, aged 20 to 50 years of age inclusive at screening. 2. Body mass index (BMI) in the range of 17.6 to 26.4 kg/m2 and body weight â‰¥45 kg. 3. Healthy as determined by the investigator on the basis of the screening evaluations. 4. Nonsmoker of smoker of fewer than 10 cigarettes per day as determined by history. 1. Presence of history of any disorder that may prevent the successful completion of the study. 2. History of drug abuse within 1 year.</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Healthy Subjects</keyword>
</DOC>